Canadian Journal of Infectious Diseases and Medical Microbiology

Research Article

Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19

Table 2

Baseline and demographic characteristics of participants (values 1: in comparison with negative control, 2: in comparison with nonsymptomatic COVID-19).


		Negative control Count	Nonsymptomatic COVID-19			Symptomatic COVID-19
		Negative control Count	N %	Count	N %	Count	N %	-value

Sex	Male	27	54.0%	27	54.0%	30	60.0%	0.784
Sex	Female	23	46.0%	23	46.0%	20	40.0%

Blood group	A+	13	26.0%	13	26.0%	12	24.0%	0.319
	A−	6	12.0%	2	4.0%	4	8.0%
	B+	11	22.0%	18	36.0%	11	22.0%
	B−	0	0.0%	5	10.0%	3	6.0%
	O+	13	26.0%	8	16.0%	13	26.0%
	O−	4	8.0%	4	8.0%	4	8.0%
	AB+	3	6.0%	0	0.0%	3	6.0%

Underlying disease	None	0	0.0%	36	72.0%	35	70.0%	0.477
	Cardiovascular disease	0	0.0%	12	24.0%	10	20.0%
	Immune deficiency	0	0.0%	2	4.0%	5	10.0%

Age	Mean	SD	-value1	-value2

Negative control	43.16	15.61
Nonsymptomatic COVID-19	48.84	18.06	0.192
Symptomatic COVID-19	41.46	13.85	0.854	0.064